INTRODUCTION
tion factors, tailless (Pignoni et al., 1990) and huckebein (Weigel et al., 1989; Brö nner and Jä ckle, 1991) , which are required for development of the embryonic head and tail. Polarity along the anterior-posterior axis of the DrosophThe Tor protein is evenly distributed along the embryonic ila embryo is established by the activity of maternal gene membrane (Casanova and Struhl, 1989) . Spatially restricted products deposited into the egg during oogenesis. These acactivation of Tor relies upon factors encoded by the fs(1) tivities direct specialized domains of zygotic gene expresNasrat (Degelmann et al., 1986) , fs(1) pole hole (Perrimon sion important for the determination of cellular fates (for et al., 1986) , torso-like (Stevens et al., 1990 ; Savant-Bhonreview see Klinger, 1990; Nü sslein-Volhard, 1991; St. Johnsale and Montell, 1993; Martin et al., 1994) , and trunk (Casston and Nü sslein-Volhard, 1992) . Spatial information at anova et al., 1995) genes. Since these products act upstream the termini, or embryonic poles, is transferred to nuclei of Tor, they are likely to play key roles in the production, through the activity of the Torso (Tor) signal transduction accessibility, and spatial distribution of the Tor ligand. pathway (for review see Lu et al., 1993b) . Localized activaOnce Tor is activated along the syncytial membrane at the tion of the Tor receptor tyrosine kinase (RTK) (Sprenger and embryonic poles, its signal is transduced to underlying nu-Nü sslein- leads to expression at the embryclei by an evolutionarily conserved set of proteins (see Perrionic poles of zygotic genes encoding the putative transcripmon, 1993 ) that include D-ras1 (Lu et al., 1993a) and the protein kinases D-raf (Nishida et al., 1988; Ambrosio et al., 1989a) , D-MEK (Tsuda et al., 1993; Hsu and Perrimon, 1994; Lu et al., 1994) , and MAP kinase (Biggs and Zipursky, 1992 ; tion conserved in all Raf family members, is essential for Raf-1 activity Fabian et al., 1993) . Biggs et al., 1994; Brunner et al., 1994) . It is through the activity of this phosphorylation cascade that the fate of nuWe have utilized the Tor pathway to learn about the regulation of D-raf and its signal transduction by microinjection clei at the poles is determined.
How the activity of D-Raf is regulated in this or other of D-raf mRNAs into Drosophila embryos. As a single large cell at early stages of embryogenesis, the Drosophila em-RTK-mediated signal transduction pathways, such as the sevenless or EGF-receptor pathways in Drosophila (Dickson bryo serves as an in vivo system in which to assay the activity and biological function of various D-raf proteins. et al., 1992; Brand and Perrimon, 1994) , is not well understood at this time. Since at the amino acid level there is
In the absence of D-raf-mediated Tor signal transduction, the embryonic head and tail fail to develop. Rescue of this 45% homology between D-raf and the human Raf-1 protooncogene (Mark et al., 1987; Nishida et al., 1988) , regulation defect by microinjection of wild-type and mutant D-raf mRNAs is used to assess whether propagation of the Tor of D-raf's activation and activity is likely similar to that of Raf-1. In mammalian cells, the Raf-1 kinase is regulated by signal has been achieved by these forms of D-raf. Here, we examine their effects without interference from endogenous multiple mechanisms. Activation of Raf-1 after stimulation of cells with growth factors is accompanied by association D-raf by preparing mutant embryos lacking maternal D-raf protein.
We tested wild-type and modified D-raf proteins of Raf-1 with Ras (Moodie et al., 1993; Van Aelst et al., 1993; Vojtek et al., 1993; Warne et al., 1993; Zhang et al., with serine substitutions that alter sites of phosphorylation in Sf9 cells, N-terminal truncations, a membrane-associated 1993; Pumiglia et al., 1995) , the translocation of Raf-1 to the plasma membrane (Leevers et al., 1994; Stokoe et al., D-raf fusion protein, and human Raf-1 to characterize their activity in the Tor signaling pathway. 1994), and hyperphosphorylation of Raf-1 . In addition, Raf-1 can associate with other proWe find that D-raf's serine/threonine kinase activity is essential for rescue of terminal defects in embryos lacking teins including hsp 90, p50 (Stancato et al., 1993; Wartmann and Davis, 1994), Fyn, Src (Williams et al., 1992 ; Cleghon maternal D-raf. We also show that human Raf-1 can interact at low efficiency with Drosophila proteins to promote Tor and Morrison, 1994) , and 14-3-3 (Fantl et al., 1994; Freed et al., 1994; Fu et al., 1994; Irie et al., 1994) . Furthermore, it signal transduction in these embryos. In addition, we identified two putative sites of D-raf phosphorylation in Sf9 cells has also been demonstrated that Ras, Raf-1, and MEK can form a ternary complex (Huang et al., 1993 (Huang et al., , 1994 show that one, serine S743, is essential for D-raf function in the Tor pathway. Alternatively, alanine substitution et Van Aelst et al., 1993; Jelinek et al., 1994) and is likely to exist as a member of a multiprotein complex (es) at residue S388 (D-raf
S388A
) did not inhibit D-raf's ability to act in Tor signal transduction. Also, we show that N- (Morrison, 1994) . Based upon the complexity of regulation for Raf-1, it is probable that in Drosophila the mechaterminal-truncated D-raf
, and a membrane-targeted D-raf tor4021 can participate in Tor signalnisms(s) utilized to regulate D-raf's activity in Tor, as well as in other RTK-mediated signal transduction pathways, is ing. However, the biological activities of these mutant Draf proteins, including D-raf
, are between 4-and 380-also complex.
D-raf shares with other Raf family members three regions fold greater than wild type, indicating that these structural modifications may distinctly alter the regulation and/or of high amino acid conservation important for its regulation and activity (CR1, CR2, and CR3). CR1, located within the propagation of the Tor signal by D-raf. N-terminal domain of the protein, mediates Raf-1 interaction with Ras and its membrane localization. Disruption of CR1 by mutation at Arg 89 prevents Raf-1 association with
MATERIALS AND METHODS
Ras and Ras-mediated activation of Raf-1 (Fabian et al., 1994) , while mutation within the cysteine finger motif
Drosophila Strains
(C 152 X 2 CX 9 CX 2 C 168 ) at Cys 168 attenuates interaction be-
In this study, wild-type Oregon R (Lindsley and Zimm, 1992 ) and tween Raf-1 and Ras (Kolch et al., 1993; Bruder et al., 1992) .
the D-raf 11-29 allele (Ambrosio et al., 1989b; Melnick et al., 1993) For D-raf, Arg 89 corresponds to Arg
217
, and mutation of this were used. To generate germline clones of D-raf [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , the ''FLP-DFS'' residue leads to a partial loss of D-raf function (Melnick et technique was utilized (Chou and Perrimon, 1992) . Flies were raised al., 1993). CR2 is a region rich in serine and threonine resion Drosophila medium at 25ЊC under standard conditions (Roberts, dues and contains Ser 259 , a major phosphorylation site of hr at 19ЊC, embryos were devitellinized with a sharp tungsten nee-(Chatsworth, CA). The DNAs were linearized, extracted with phenol (pH 7.4), precipitated with 0.1 vol of 3 M sodium acetate and dle and Halocarbon oil (series 95, Halocarbon Products Corp.) was removed from each embryo with heptane. These cuticular prepara-1.5 vol of ethanol, and then dissolved in DEPC-treated distilled water. mRNAs were generated using the mMESSAGE mMACHtions of embryos were embedded in a (1:1) mixture of Hoyer's:lactic acid according to van der Meer (1977) and photographed with a INE SP6 RNA polymerase kit from Ambion (Austin, TX) and then dissolved in nuclease-free distilled water at 1.0 mg/ml. Zeiss Axioscope microscope using dark-field illumination or Nomarski optics.
For in vitro translation, in vitro synthesized mRNAs were translated using a rabbit reticulocyte lysate kit (Amersham). Each reacThe D-raf gene is located on the X-chromosome and its product is required at multiple stages of development. Without injection, tion contained 10 ml of reticulocyte lysate, 2 ml of 1 M potassium acetate, and 1 mg of in vitro synthesized mRNA. Samples were embryos that lack maternal D-raf protein show two phenotypic classes (Ambrosio et al., 1989b) . Male embryos that lack maternal incubated for 1 hr at 37ЊC and analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. and paternal D-raf protein show little cuticle differentiation and are not considered in this analysis. Female embryos lack maternal D-raf protein but inherit a paternal X-chromosome with a wild-
Expression of D-raf Proteins in Sf9 Cells
type copy of the D-raf gene. These female embryos are defective only for the Tor signaling pathway. In our analysis, we address the To obtain recombinant baculoviruses expressing mutant D-raf question of posterior rescue for these female embryos. Thus, since proteins, DNA fragments containing wild-type and mutant D-raf the D-raf gene product acts in several different developmental pathcoding sequences were isolated using the restriction enzymes NcoI ways, only its maternal role in the Tor pathway has been addressed and EcoRI and were inserted into the corresponding sites in the here.
pAcC4 baculoviral transfer vector. Each of the recombinant transfer vectors was then cotransfected into Sf9 cells with wild-type AcNPV
Plasmid Constructions
DNA, and recombinant baculoviruses were isolated by plaque puriWild-type D-raf plasmid is as described by Sprenger et al. (1993) ; fication as described by Summers and Smith (1987) . Raf-1 is as in Fabian et al. (1993) ; and Raf-1 D305 is as in Samuels et al. (1993) .
Site-directed mutagenesis. The plasmid pGEM7GLO was gen-
Phosphopeptide Mapping
erated by inserting a 2.7-kb HindIII-EcoRI fragment from For peptide mapping, 32 P-labeled proteins isolated from Sf9 cells pSP64GLO, which contained the entire coding sequence of the Dwere separated by SDS-polyacrylamide gel electrophoresis (PAGE), raf gene (residues 1-782) inserted downstream of a 56-bp 5-uneluted from the gel matrix, TCA precipitated, and subjected to translated leader sequence from the Xenopus b-globin gene, into enzymatic digestion with trypsin. Labeled polypeptides were sepathe corresponding sites of plasmid pGEM7Z(0) (Promega). Singlerated on thin layer cellulose plates by electrophoresis at pH 1.9 for stranded plasmid used for mutagenesis was produced from the plas-27 min at 1000 V, followed by ascending chromatography in a mid pGEM7GLO upon infecting host cells with the helper phage buffer containing n-butanol:pyridine:acetic acid:water in a ratio of M13K07 (Vieira and Messing, 1987) . Oligonucleotides were synthe-75:50:15:60. sized to generate the mutations K497M (5-CCCGTGCCCGTA-ATGACACTCAACGTG-3), S388A (5-CAAGACGATCGATCC-AATGCCGCGCCAAATGTG-3), and S743A (5-CATCGCAGT-
Western Analysis of D-raf from Microinjected
GCCGCTGAACCAAACTTG-3). Mutants were generated by the Embryos method of Kunkel et al. (1987) , as described by the vendor (for Bio-Rad Mutagenesis Kit, Richmond, CA), and each mutation was Translation of injected mRNA in embryos was examined by confirmed by sequencing using a custom primer and the Sequenase Western blot analysis. After injection, the embryos were incubated Version 2.0 DNA sequencing kit (United States Biochemical, at room temperature for 1 hr and then the Halocarbon oil was Cleveland, OH). removed with heptane. To make extracts, the embryos were transDeletion mutants. The deletion mutant D-raf D315 was generferred into an Eppendorf tube and homogenized in lysis buffer conated by removing a 0.9-kb NcoI fragment (encoding amino acids taining 1% Nonidet P-40, 20 mM Tris (pH 8.0), 137 mM NaCl, 1-315) from the construct pGEM7GLO and religating the plasmid. 10% glycerol, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, Deletion mutants D-raf D370 and D-raf tor4021 were generated as deaprotinin (0.15 U/ml), 20 mM leupeptin at a concentration of 1 scribed by Dickson et al. (1992) . The deletion mutant D-raf D445 was embryo per 1 ml (see Sprenger et al., 1993) . Insoluble material was generated by PCR using the oligos 5-CCGCGGCCATGGCCAremoved by centrifugation at 4ЊC for 10 min at 10,000g. TGAGAGCAATAAAAATCTGC-3 and 5-GGCCCGACGTCG-D-raf protein was immunoprecipitated as described in Sprenger CATGCTCCTCTAGACTCGAGG-3 as the 5 and 3 PCR primet al. (1993) . Immunoprecipitates were resolved by 7.5% SDSers, respectively. A 1.4-kb fragment was amplified (35 cycles of PAGE and transferred to 0.2-mm-pore nitrocellulose membrane fil-94ЊC, 1.0 min; 56ЊC, 1.0 min; and 72ЊC, 2.0 min), extracted with ters (Schleicher & Schuell) electrophoretically. These filters were chloroform, ethanol precipitated, and subsequently digested with blocked with 2% bovine serum albumin (Sigma) in Tris-buffered NcoI and EcoRI. The PCR fragment was gel purified, extracted, and saline, pH 8.0 (TBS), for 1 hr, washed in TBST (TBS containing ligated into gel-purified pGEM7GLO which had been digested with 0.2% Tween 20), and probed for 2 hr with primary antibody diluted NcoI and EcoRI.
in TBST. The filters were then washed in TBST, incubated with a horseradish peroxidase-coupled secondary antibody for 1 hr, and
In Vitro Transcription and Translation
washed again in TBST. They were developed by using an enhanced chemiluminescence system (Amersham) and visualized on Kodak For in vitro transcription, the template plasmid (pGEM7 / Draf cDNA) was purified using the Plasmid Midi kit from Qiagen XAR-5 film. 
Kinase Activity of D-raf Is Essential for Its Role in Terminal Development
To determine whether the Tor signal transduction pathway could be reconstituted in embryos that lack maternal D-raf protein, we microinjected mRNA encoding either a wild-type D-raf (D-raf WT ) or a kinase-defective mutant D-raf (D-raf K497M ) into embryos lacking maternal D-raf protein. These embryos were derived from mothers homozygous mutant for the D-raf 11-29 allele in their germlines (Chou and Perrimon, 1992) . Figure 1 shows a schematic represen- of this analysis are summarized in Table 1 . To confirm the protein, as expected for D-raf, was synthesized (data not shown). These results show that the kinase activity of Dintegrity of the mRNAs used in this assay, D-raf mRNAs were translated in rabbit reticulocyte lysates and a 90-kDa raf is essential for its function in the Tor signaling pathway. 
Age-Dependent D-raf-Mediated Rescue
conservation of structure among the components of this signaling cascade such that activator(s) and substrate(s) of Tor protein first appears at nuclear cycle 4 (NC 4) on the D-raf are recognized by and can recognize human Raf-1 prosurface of the embryonic membrane (Casanova and Struhl, teins. 1989 ) and zygotic tailless gene expression begins about 60 min later at NC 11 (Pignoni et al., 1990 (Pignoni et al., , 1992 . It is during this interval that activation of Tor and D-raf is required to transduce the terminal signal from the membrane into nu-
Identification of D-raf Phosphorylation Sites
clei at the embryonic poles. To determine when activation of D-raf is required to transmit the Tor signal, D-raf WT Phosphorylation may be a mechanism by which the activity of D-raf is regulated. Maternal D-raf protein becomes mRNA at 1 mg/ml was injected into embryos that lack maternal D-raf protein. When embryos were injected at NC phosphorylated 2 hr after fertilization in wild-type embryos (Sprenger et al., 1993) . At this time the Tor RTK has been 6-8 or NC 9-10, 83 and 75% of the embryos developed Filzkö rper, respectively (Table 2) . However, at NC 12-13 activated and the intracellular signal generated for zygotic expression of tailless. have identified the percentage rescue was dramatically reduced (23%) and at NC 14 after the onset of cellularization none of the inthe major phosphorylation sites of the Raf-1 kinase in mammalian and recombinant baculoviral-infected Sf9 insect jected embryos developed Filzkö rper. Sprenger and Nü sslein-Volhard (1992) observed a similar age-dependent rescue cells. Sequence comparison reveals that two of these phosphorylation sites (S259 and S621) and the residues surof tor mutant embryos after the injection of tor mRNA. This experiment indicates that the optimal period of activarounding these serines (RSXSXP) are conserved in all Raf family members, indicating that these sites of phosphorylation and signal transduction by D-raf in the Tor pathway is between NC 6 and 12. For the experiments described below, tion may be required for the enzymatic activity or regulation of the Raf kinases. These serine residues correspond to mRNAs were injected into embryos at stages NC 6-9 of embryonic development. Mark et al., 1987; Nishida et al., 1988) , we tested sates, separated by electrophoresis on SDS-polyacrylamide gels, extracted, digested with trypsin, and the phosphopepthe ability of human Raf-1 to act in the Drosophila Tor signal transduction pathway. In this experiment, 1 mg/ml in tides were analyzed by two-dimensional peptide mapping (Fig. 4) . For D-raf WT five labeled peptides were observed vitro synthesized Raf-1 mRNA ( Fig. 4B ) and D-raf S743A (Fig. 4C) , phosphopeptides A and B, raf protein. After injection, 70 embryos developed, and of these 4 embryos showed terminal Filzkö rper (5.7% rescue).
respectively, were absent. This analysis indicates that serine residues 388 and 743 serve as putative D-raf phosphoryThus, Raf-1 can interact at low efficiency with Drosophila proteins in the Tor pathway. We also tested whether a lation sites in Sf9 cells and suggests that these sites may also be phosphorylation sites in the Drosophila embryo. In highly transforming N-terminal deletion of human Raf-1, Raf-1 D305 (Samuels et al., 1993) , could substitute for D-raf addition, since the phosphopeptide map of kinase-defective D-raf K497M is identical to that of D-raf WT , it is unlikely that in embryos that lack maternal D-raf activity. In this case, 11% rescue of Filzkö rper was achieved after injection of 1 the phosphorylated peptides result from D-raf autophosphorylation (data not shown). mg/ml Raf-1 D305 mRNA. These results indicate that there is 
Signaling Activity of D-raf Proteins with Serine to
mRNAs encoding these and D-raf S388A/S743A double mutant proteins were injected into the posterior of embryos lacking Alanine Substitutions maternal D-raf protein (see Fig. 1 ). After 48 hr embryos were To determine whether substitution of alanine at serine scored for the presence of Filzkö rper (Table 3) . After injecphosphorylation site 388 or 743 alters the ability of D-raf to tion with D-raf S388A mRNA, rescue of posterior pattern was participate in the Tor pathway, 1 mg/ml in vitro synthesized observed (Fig. 5A) (Bonner et al., 1985; Rapp et al., 1988) . Thus, removal of these residues relieves Raf-1 from negative regulation a Male embryos from D-raf mutant germlines do not develop cuticles (Materials and Methods). (Heidecker et al., 1990) . We tested whether D-raf proteins having N-terminal truncations would substitute for wildRaf-1 kinase (Leevers et al., 1994; Stokoe et al., 1994 ). Therefore, we tested a deletion mutation, D-raf tor4021 , which type D-raf in the Tor pathway (see Fig. 1 ). For this analysis three deletions of D-raf were tested, D-raf . D-raf D315 lacks CR1, which contains the putative Ras-1 binding domain and the cysteine finger region. Dmembrane domains of the Tor protein (see Fig. 1 ). In Draf tor4021 , the extracellular domain of Tor has a substitution raf D370 lacks CR1 and part of CR2, but retains the rest of CR2 and the serine/threonine kinase domain (CR3). Dof cysteine for tyrosine at position 327 that renders the protein constitutively active (Sprenger and Nü sslein-Volhraf D445 encodes only CR3. As shown in Table 3 , when 1 mg/ml of each of these deleted forms of D-raf mRNAs was ard, 1992). This fusion protein has previously been shown to induce R7 development in the Sevenless/D-ras1 signal injected into the posterior of embryos lacking maternal Draf protein, greater than 50% rescue of Filzkö rper was transduction pathway in the absence of Sevenless RTK activity (Dickson et al., 1992) . achieved. Figures 5C and 5D show two embryos that lack maternal D-raf protein after injection of D-raf D370 and DWhen 1 mg/ml of D-raf tor4021 mRNA was injected into the posterior of embryos that lack maternal D-raf protein, resraf D445 mRNAs, respectively. Both embryos show rescue of posterior pattern. Rescue of head structures was also obcue of posterior Filzkö rper was observed. However, in these experiments many of the embryos produced weak cuticles served after anterior injection of D-raf
D315
, D-raf D370 , and D-raf D445 mRNAs (data not shown). These results indicate that ruptured during the process of mounting. Other embryos had cuticles that appeared faint or crinkled in which that N-terminal-truncated D-raf molecules can recognize and interact with their substrate(s) to transmit the Tor sigterminal as well as abdominal structures were difficult to score. Therefore, we tested the effect of microinjection usnal in embryos.
It has also been shown that targeting Raf-1 to the plasma ing 0.25 mg/ml of D-raf tor4021 mRNA. As shown in Table 3 , rescue of Filzkö rper was observed for 92% of the injected membrane results in a Ras-independent, active form of the ml only 10% rescue of Filzkö rper was observed. Thus, it appears that there is a threshold level of wild-type activity required to achieve a high degree of terminal rescue. To determine the relative biological activity of wild-type and mutant D-raf mRNAs, we calculated the approximate concentration of mRNA needed for injection to achieve 80% terminal rescue. For D-raf WT approximately 0.76 mg/ml mRNA would be required. Similarly, to achieve 80% rescue the approximate concentration of mRNA required for injection of D-raf D445 is 0.097 mg/ml mRNA, while for D-raf S388A 0.030 mg/ml mRNA is required, and for D-raf tor4021 0.002 mg/ ml mRNA is required (Fig. 6) embryos, and very few embryos produced weak cuticles. An example of a rescued embryo is depicted in Fig. 5E . Interestingly, a second effect of D-raf tor4021 was observed, and this is shown in Fig. 5F (arrows). For some embryos the region containing the anal plates was enlarged and this expansion was accompanied by deletion of part or all of abdominal segment eight, which is also specified by the Tor pathway. Thus, unlike wild-type, D-raf 
Relative Biological Activity of Wild-Type and Mutant D-raf mRNAs
Since serine substitution at S388A, amino-terminal truncation, and membrane targeting may affect regulation of and signaling by D-raf, we determined the relative biological , and D-raf tor4021 mRNAs (Fig. 6 ). In these experiments to develop for 60 min, and then processed for Western analysis.
a similar volume of mRNA was injected into each embryo and at each mRNA concentration tested more than 50 emproteins that accumulate after injection of 1 mg/ml of the correbryos with developed cuticles were scored. was achieved, respectively, while at approximately 0.36 mg/ mRNAs are 25-and 380-fold more active, respectively, than ing of ligand molecules to receptor tyrosine kinases that dimerize, leading to their transphosphorylation on tyrosine wild-type D-raf mRNA.
Since less than wild-type levels of mRNA were required residues (see van der Greer et al., 1994 ). These phosphotyrosines then serve as attachment sites for the adapter protein, to achieve a high percentage of embryonic rescue, the concentration of each mutant protein produced in vivo was Drk, which recruits the guanine nucleotide-releasing factor Son of Sevenless (SOS) to form the membrane-associated determined. Figure 7A shows the results of this experiment, in which embryonic lysates were compared after injection activating complex for Ras. In turn, Ras promotes Raf membrane association, and this complex phosphorylates and ac-
mRNA. For each sample, 100 embryos were injected, altivates MEK, a protein kinase with dual specificity (see Marshall, 1995) . MEK then activates MAPK, which is then lowed to develop for 60 min, and then processed for Western analysis. The relative level of each mutant protein synthetranslocated to the nucleus where it phosphorylates transcription factors that regulate gene expression. In the case sized was determined by comparing its level of accumulation to that found after injection of 1 mg/ml wild-type D-raf of the Tor pathway, an unknown transcription factor(s) is responsible for expression of the terminal zygotic genes mRNA. For D-raf S388A , a 90-kDa D-raf protein accumulates at a concentration of approximately one-half that observed tailless and huckebein (see Lu et al., 1993b) . (Sprenger et al., 1993) . In addition, Melnick et al. (1993) showed that two mutamRNAs (data not shown). Thus, in these experiments an equivalent amount of D-raf tor4021 , one-half the quantity of tions of D-raf that gave a null phenotype in the Tor pathway were associated with single amino acid substitutions within D-raf S388A and 2-fold more D-raf D445 protein accumulated compared to wild-type. If protein concentration is then conserved regions of the D-raf kinase domain. These two findings strongly indicate that D-raf functions as a serine/ taken into consideration when calculating biological activity, D-raf tor4021 mRNA is 380-fold more active, D-raf S388A threonine kinase in Drosophila and that this activity is required for Tor signal transduction. However, a kinase-demRNA is 50-fold more active, and D-raf D445 mRNA is four times as active as wild-type D-raf mRNA.
pendent as well as an independent requirement, related to subcellular localization and/or participation in a multiprotein complex, has been shown for the Drosophila Abelson tyrosine kinase (Henkemeyer et al., 1988 (Henkemeyer et al., , 1990 ). Here we
DISCUSSION
show directly that a point mutation known to inactivate the D-raf serine/threonine kinase in vitro (Sprenger et al. , The Tor pathway is activated when the Drosophila embryo is a syncytium. As a large single cell, the Drosophila 1993) also abrogates the ability of the protein to act in the Tor pathway in vivo. Thus, D-raf's kinase activity is essenembryo is easily amenable to phenotypic rescue by microinjection. Since mutations in various gene products of the tial for D-raf function in Tor signal transduction. Tor pathway have been characterized they serve as good backgrounds in which to add wild-type or mutant D-raf
Conservation of Structure and Function of Signal
proteins and to assay the activity of altered signaling com-
Transduction Molecules
ponents. Thus, we have used the Tor signal transduction pathway to test the function of modified D-raf proteins in
In order to test the evolutionary conservation of the Tor signal transduction pathway, we tested whether human Rafan in vivo developmental context. D-raf mutations were generated to address the mechanism(s) that regulates its 1 could substitute for D-raf in Drosophila embryos. Fulllength human Raf-1 replaced D-raf in the Tor pathway at kinase activity or facilitates access to its substrate(s). This system offers a rapid approach for structure/function analylow efficiency, but the highly transforming N-terminal-deleted form of Raf-1 was twice as active. Overall, these resis of the Raf family of serine/threonine kinases as well as other molecules that participate in the evolutionarily sults show that there is structural conservation between the components of this signaling cascade and that activaconserved signaling module utilized by receptor tyrosine kinases for transmission of cellular signals (see Perrimon, tor(s) and substrate(s) of D-raf are recognized by and can recognize the human Raf-1 proteins. Therefore, it is likely 1993).
In general, signal transduction begins following the bindthat we can use the genetics of Drosophila to gain a better understanding of the mechanisms utilized for signal transthe truncated D-raf molecules recognize, have access to, and can interact with the substrate(s) of the full-length wildduction as it pertains to the control of growth and development in higher organisms.
type D-raf protein. This result is significant because we show that truncated forms of D-raf can act in the absence of and independent of wild-type D-raf. Thus, oncogenic
Phosphorylation as a Mechanism for D-raf
forms of Raf-1 may act in a similar manner in mammalian Regulation cells that contain wild-type Raf-1 proteins. Next, we addressed the effect on Tor signal transducProtein kinases and phosphatases play a critical role as mediators in signal transduction pathways. Reversible protion of a membrane-targeted N-terminal-truncated D-raf. In mammalian cells, targeting of Raf-1 to the plasma tein phosphorylation is a good mechanism by which to regulate developmental choices. Indeed, it has recently been membrane results in a Ras-independent, active form of the Raf-1 kinase (Leevers et al., 1994; Stokoe et al., 1994) . shown that reversal of Raf-1 activation is achieved by purified and membrane-associated protein phosphatases , a chimeric D-raf protein used in this study, is directed to the membrane through the Tor signal seet al., 1995) . Two putative phosphorylation sites have been mapped for the D-raf kinase isolated from Sf9 cells, serine quence and was shown to induce R7 development in the Sevenless/D-ras1 signal transduction pathway in the abresidues S388 and S743. These two residues and surrounding residues (RSXSXP) are conserved among members sence of Sevenless RTK activity (Dickson et al., 1992) . Thus, this chimeric form of D-raf probably has constituof the Raf family of protein kinases and correspond to serines 259 and 621 of the Raf-1 protein .
tive activity in all cell types in which it is expressed. Here we test whether D-raf tor4021 can substitute for wild-type Since phosphorylation occurs at these sites for the kinasedefective D-raf K497M protein, these events are not due to D-raf and transmit the Tor signal in the absence of maternal D-raf protein. We find that D-raf tor4021 promotes formaautophosphorylation and appear to be dependent upon another kinase(s). These results suggest that in Drosophila tion of terminal structures and at high concentrations can cause the expansion of some posterior elements within embryos, these sites are potentially important for the regulation of D-raf activity.
the terminal domain. This result indicates that higher than wild-type levels of D-raf activity are produced by DSubstitution of an alanine at residue S743 rendered the D-raf protein inactive, while substitution at site S388 was raf tor4021 and is consistent with the idea that D-raf tor4021 acts constitutively in the Tor signaling pathway. permissive and resulted in rescue of the D-raf maternal effect. This result is consistent with that observed for Raf-1 when the homologous amino acid substitutions were Relative Biological Activity of Wild-Type and tested. In in vitro kinase assays Raf-1 S621A had no activity,
Mutant D-raf mRNAs
while Raf-1 S259A showed a threefold increase in kinase activity compared to that of wild-type Raf-1 (Morrison et al., The maternal terminal system defines the spatial expression patterns of the tailless (tll) and huckebein (hkb) genes. 1993). Unlike wild-type Raf-1, Raf-1 S259A did not associate with 14-3-3 and showed Ras-independent enzymatic activTranscriptional activation of tll requires a low level of Draf activity and occurs in nuclei that lie within the presumpity as assayed by the induction of meiotic maturation in Xenopus oocytes (Michaud et al., 1995) . It is likely that tive tail region, at 0-20% egg length. High levels of D-raf activity promote hkb expression and are restricted to nuclei functional conservation at these two phosphorylation sites is indicative of an evolutionarily conserved mechanism that at 0-12% egg length (Melnick et al., 1993) . In this study we define rescue of the Tor pathway by scoring development of modulates Raf activity. Thus, phosphorylation could serve to alter the conformation of the Raf protein, its enzymatic Filzkö rper that require tll, but not hkb expression (Weigel et al., 1989) . However, many of the rescued embryos contain activity, its interactions with other molecules, or a combination of these modifications.
pattern elements that are induced by hkb expression (Baek and Ambrosio, unpublished data). Although we assay biological function of D-raf simply at the activity level that
Regulation of N-Terminal Deletion Mutants
triggers tll expression, in many embryos it is probable that of D-raf expression of hkb is also induced. When the biological activity of D-raf WT was characterized In mammalian cells, N-terminal truncation of Raf-1 leads to increased Raf-1 kinase activity and oncogenic transforat low concentrations of D-raf mRNA (0.36 mg/ml), 10% of the injected embryos developed Filzkö rper. However, at a mation (Stanton et al., 1989; Heidecker et al., 1990 ). Here, we tested whether truncated versions of D-raf can substislightly higher concentration (0.5 mg/ml) 72% rescue of Filzkö rper was observed. This indicates that there is a critical tute for full-length D-raf and transmit the Tor signal in embryos that lack maternal D-raf protein. We tested three threshold of D-raf activity required to promote Filzkö rper formation. At twice this concentration (1.0 mg/ml) 99% of different N-terminal deletions, each encoding the D-raf kinase domain, that effectively participated in signal transthe embryos developed Filzkö rper. We designated 80% rescue as a good measure of D-raf biological function and then duction. These results indicate that at least a fraction of compared the concentration of wild-type and modified as wild-type D-raf protein to the membrane, this question may be addressed. Further characterization of these modiforms of D-raf mRNA required to achieve this level of rescue.
fied forms of D-raf in embryos lacking the activity of upstream pathway components will provide additional clues When the relative biological activity of each modified form of D-raf was determined in vivo and normalized for toward understanding the mechanisms utilized in wild-type cells to promote transduction of a signal from the memprotein concentration, the activity of D-raf tor4021 mRNA was 380-fold greater, D-raf S388A mRNA was 50-fold more brane to the nucleus. active, and D-raf D445 mRNA was four times as active as wild-type D-raf mRNA. These differences in biological activity levels are likely related to the structural and confor- , and p50 proteins (see Morrison, 1994 Krantz et al., 1994) . It is unknown Bonner, T. I., Kerby, S. B., Gunnell, M. A., Mark, G. E., and Rapp, whether a similar multiprotein kinase complex that con- signal can be transduced. Brand, A., and Perrimon, N. (1994 
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